In kitchens across Hong Kong, two people eat the same bowl of oatmeal and walk away with different outcomes — a quiet reminder that the body is never a simple machine. New research explored by Dr. Wang Szu-heng suggests that gut bacteria, unique to each individual, transform oat polyphenols into compounds that suppress cholesterol production along the same pathway targeted by statin drugs, explaining why oatmeal's benefits have always been unevenly distributed. The traditional story of fiber binding cholesterol remains true, but incomplete — beneath it lies a living, invisible partnership betw